Viewing Study NCT03495206


Ignite Creation Date: 2025-12-26 @ 4:00 PM
Ignite Modification Date: 2025-12-29 @ 12:46 PM
Study NCT ID: NCT03495206
Status: UNKNOWN
Last Update Posted: 2020-02-17
First Post: 2018-03-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability and Pharmacokinetics of Y-2(Edaravone And Borneol) Sublingual Tablet
Sponsor: Yantai YenePharma Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module